Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 118 results found. Search for [ Russian Direct Investment Fund (RDIF) ]

Results 1 to 21 of 118
PTI
June 20, 2021
A spokesperson of Apollo Hospitals said the facility in Delhi will tentatively start administering the two-dose vaccine by June 25


BusinessToday.In
June 17, 2021
The two hospitals that are participating in the pilot roll-out of Sputnik V are Fortis Memorial Research Institute, Gurugram and Fortis Hospital, Mohali


BusinessToday.In
June 3, 2021
Once the company gets permission, it will have to conduct clinical trials and if successful, the Serum Institute will become the seventh company to manufacture Sputnik V


PTI
June 1, 2021
A GMR Hyderabad Air Cargo (GHAC) press release said the vaccine consignment arrived from Russia on a specially chartered freighter RU-9450 which touched down at Hyderabad Airport at 03.43 hours


BusinessToday.In
May 25, 2021
The company informed that the full-scale production of the vaccine is due to start this summer. It further added that the first batch produced at Panacea Biotec's facilities at Baddi will be shipped to the Gamaleya Center for quality control


BusinessToday.In
May 25, 2021
Stocks in news: Grasim Industries, Infosys, Dalmia Bharat Sugar, ICICI Securities, Bharti Airtel, India Cements and more


PTI
May 24, 2021
As announced in April, the Russian Direct Investment Fund (RDIF) - which markets the vaccine internationally, and Panacea Biotec agreed to produce 100 million doses per year of Sputnik V in India


BusinessToday.In
May 24, 2021
First batch produced at Panacea Biotec's facilities at Baddi will be shipped to the Gamaleya Centre for quality control. Full-scale production of the vaccine is due to start soon


BusinessToday.In
May 18, 2021
This would be the first time in the country when a COVID-19 vaccine will be tested on children. The clinical trials will involve two COVID vaccine shots injected on day 0 and day 28 and will take place at several sites -- AIIMS, Delhi; AIIMS, Patna; and Meditrina Institute of Medical Sciences, Nagpur


BusinessToday.In
May 17, 2021
The targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses (50 million of Component 1 and 50 million of component 2), from the date of start of commercial production


BusinessToday.In
May 17, 2021
Dr Reddy's Laboratories CEO - Branded Markets (India & Emerging Markets) MV Ramana said the two entities are working to scale up the pilot and take the vaccine to other cities.


Anwesha Madhukalya
May 17, 2021
Sputnik V has been priced at Rs 948 + 5 per cent GST per dose, amounting to Rs 995. However, the vaccine is being administered at a price of Rs 1,250 per dose at Jubilee Hills Apollo


Manoj Sharma
May 17, 2021
The current vaccine makers, Serum Institute and Bharat Biotech, alone won't be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead


BusinessToday.In
May 16, 2021
Russian Ambassador to India Nikolay Kudashev termed the delivery of the second consignment of Sputnik V vaccine in the country \"very timely\"


BusinessToday.In
May 15, 2021
\"We have asked them (Dr Reddy's) how many doses and by what time they can provide. No response has come from their side as yet,\" Kejriwal said.


BusinessToday.In
May 14, 2021
The double-dose Sputnik V was launched in the Indian market by Dr Reddy's Laboratories on Friday. The vaccine is priced at Rs 995 per dose


Reuters
May 14, 2021
The Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said the manufacturing capacity for Sputnik V was increasing globally as new manufacturers come on board.


BusinessToday.In
May 14, 2021
The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5% GST per dose, with the possibility of a lower price point when local supply begins, says RDIF's Indian partner Dr Reddy's Lab


BusinessToday.In
May 13, 2021
Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers


BusinessToday.In
May 7, 2021
They are as reliable as an AK-47. By the way, it wasn't us who said that, this was said by a European specialist. And I think that he is certainly right, Putin said during a video conference with Deputy PM Tatyana Golikova


PAGES 1 OF 6  12345